PremiumMarket NewsOrchard Therapeutics Ends Key Financial Agreement Post-Transaction Soleno Therapeutics announces appointments to its leadership team Orchard Therapeutics receives Swissmedic approval for Libmeldy PremiumThe FlyOrchard Therapeutics downgraded to Hold from Buy at Stifel Orchard Therapeutics to be acquired by Kyowa Kirin for $16.00 per share Biotech Alert: Searches spiking for these stocks today PremiumThe FlyOrchard Therapeutics completes submission of BLA for OTL-200 in MLD to U.S. FDA Orchard Therapeutics supports enactment of Newborn Metabolic Screening Act Orchard Therapeutics announces second closing of strategic financing 
